Srikripa Devarakonda
Stock Analyst at Truist Securities
(0.78)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
REGN Regeneron Pharmaceut... | Maintains: Buy | 940 812 | 546.18 | 48.67% | 8 | Aug 11, 2025 | |
INCY Incyte | Maintains: Hold | 73 79 | 79.21 | -0.27% | 11 | Jul 30, 2025 | |
ARVN Arvinas | Downgrades: Hold | 21 11 | 6.58 | 67.17% | 1 | May 5, 2025 | |
BIIB Biogen | Maintains: Buy | 210 199 | 128.03 | 55.43% | 4 | Apr 29, 2025 | |
KROS Keros Therapeutics | Maintains: Buy | 43 25 | 13.35 | 87.27% | 5 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 60 76 | 53.77 | 41.34% | 2 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 1029 1038 | 635.48 | 63.34% | 4 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 211 217 | 198.62 | 9.25% | 3 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 36 32 | 24.61 | 30.03% | 1 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 33 50 | 12.99 | 284.91% | 6 | Nov 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 36 45 | 31.47 | 42.99% | 4 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 54 53 | 37.69 | 40.62% | 3 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 54 54 | 1.52 | 3452.63% | 1 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 18 15 | 7.7 | 94.81% | 7 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 36 | 9.64 | 273.44% | 1 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 86 70 | 33.2 | 110.84% | 4 | May 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 80 60 | n/a | n/a | 2 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 38 | n/a | n/a | 3 | Mar 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 50 34 | 33.99 | 0.03% | 2 | Jun 3, 2021 |